Results 151 to 160 of about 29,473,219 (216)

Investigating cochlear cellular dynamics in neurofibromatosis type 2-associated schwannomatosis: a histopathological study. [PDF]

Front Neurol
Al-Asad RK, Montigny DJ, O'Malley JT, Welling DB, Jung DH, Eckhard AH, Kempfle JS.   +6 more
europepmc   +1 more source

Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration. [PDF]

Acta Neuropathol Commun, 2023
Teranishi Y, Miyawaki S, Nakatochi M, Okano A, Ohara K, Hongo H, Ishigami D, Sakai Y, Shimada D, Takayanagi S, Ikemura M, Komura D, Katoh H, Mitsui J, Morishita S, Ushiku T, Ishikawa S, Nakatomi H, Saito N.   +18 more
europepmc   +1 more source

Matrix Metalloproteinase‑9 (MMP-9) Activatable Gold Nanoparticles for <i>In Situ</i> Zymography and Diagnostics of Neurofibromatosis Type 2 (NF2) Tumors. [PDF]

ACS Appl Nano Mater
Kaushal S, Nguyen HTN, Fisher M, Kuo HC, Schultz ZD, Ren Y.   +5 more
europepmc   +1 more source

Short‑term efficacy assessment of brigatinib for the treatment of neurofibromatosis type 2: A retrospective study. [PDF]

Oncol Lett
Lin Z, Yu W, Jing F, Xu Z, Liu M, Jiao S.   +5 more
europepmc   +1 more source

Context-specific targeting of focal adhesion kinase in brain tumors: lessons from glioblastoma and neurofibromatosis type 2-mutant meningioma. [PDF]

Front Oncol
Sagerer A, Eyüpoglu IY, Juratli TA, Cordes N.   +3 more
europepmc   +1 more source

Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2: a systematic review and meta-analysis. [PDF]

BMC Cancer
Hajikarimloo B, Tos SM, Alvani MS, Kooshki A, Mohammadzadeh I, Habibi MA.   +5 more
europepmc   +1 more source

Neurofibromatosis Type 2: A Rare Case of Multiple Intracranial Schwannomas, Meningiomas, and Ependymomas (MISME) Syndrome and Literature Review. [PDF]

Cureus
Hamza L, Yahya N, Wafa H, Loubna C, Sara L, Nawal A.   +5 more
europepmc   +1 more source

Management Strategies of Neurofibromatosis Type 2 in Pediatric Patients : Challenges and Emerging Therapies. [PDF]

J Korean Neurosurg Soc
Lee JS.
europepmc   +1 more source

Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study. [PDF]

JMIR Hum Factors
Desroches ST, Huang A, Ghankot R, Tommasini SM, Wiznia DH, Buono FD.   +5 more
europepmc   +1 more source

Efficacy of Combined Dabrafenib and Trametinib Therapy in BRAFV600E Mutant Intrahepatic Cholangiocarcinoma with a Neurofibromatosis Type 2 Mutation. [PDF]

Intern Med
Yoshida J, Sugiyama K, Owaki S, Ito T, Yamaguchi Y, Emi R, Sako Y, Satoh M, Ino R, Kato K, Shiraishi K, Shimada M, Hattori H, Kitagawa C.   +13 more
europepmc   +1 more source